Moderna Vaccine Increases Myocarditis Risk by 44 Times in Young Adults: Peer-Reviewed Study

The risk was 13 times higher with Pfizer vaccination

Vials with Pfizer-BioNTech and Moderna COVID-19 vaccine labels are seen in this illustration picture taken on March 19, 2021. Dado Ruvic/Illustration/Reuters

A French peer-reviewed study concluded that for both the Pfizer and Moderna vaccines, the risk of myocarditis skyrockets a week after vaccination.

The risk of myocarditis after mRNA vaccination was 8 times and 30 times greater than unvaccinated control groups for BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna), respectively.